Martin Parkinson

News and Video Search Results

News coverage

Eli Lilly's and AstraZeneca's Former Head of Research Dr. Jan Lundberg Invests in AlzeCure and is Proposed for Election to its Board

Accesswire 10 Apr 2024

*STOCKHOLM, SWEDEN / ACCESSWIRE / April 10, 2024 /* AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB ("AlzeCure" or "the..

Data from Newron’s study 014/015 and an evenamide clinical development outlook presented at the 2024 Annual Congress of the Schizophrenia International Research Society (SIRS)
EQS Group 08 Apr 2024
AlzeCure Pharma Publishes its Annual Report for 2023
Accesswire 04 Apr 2024
AlzeCure Presents New Data Regarding the TrkA-NAM Pain Project at IASP 2024
Accesswire 03 Apr 2024
Newron presents 2023 financial results and provides 2024 outlook
EQS Group 19 Mar 2024

0 shares 1 views

You might like

Martin Parkinson media coverage

Newron announces agreement with the European Investment Bank (EIB) to extend the near-term tranche repayment dates of its 2018 financing agreement

EQS Group 15 Mar 2024

EQS-News: Newron Pharmaceuticals S.p.A. / Key word(s): Financing
Newron announces agreement with the European Investment Bank..

Newron enters into an agreement for the subscription of up to 2.05 million newly issued shares; Proceeds of up to EUR 15.0 million
EQS Group 14 Mar 2024
AlzeCure to Partake in Redeye Theme: Alzheimer on March 21
Accesswire 14 Mar 2024
AlzeCure Presents New Preclinical Data with NeuroRestore ACD856 at Leading Alzheimer's Conference
Accesswire 07 Mar 2024
AlzeCure Publishes Clinical Results Supporting Continued Development of NeuroRestore ACD856 Against Alzheimer's
Accesswire 05 Mar 2024

Advertisement

More coverage

AlzeCure's Alzheimer's Project NeuroRestore ACD856 is Granted an Additional Patent

Accesswire 29 Feb 2024

*STOCKHOLM, SWEDEN / ACCESSWIRE / February 29, 2024 / *AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:..

AlzeCure Publishes its Year-end Report for January - December 2023
Accesswire 27 Feb 2024
AlzeCure Pharma Broadcasts Live Expert Event on Alzheimer's Around Highly Current Gamma-Secretase Modulators
Accesswire 12 Feb 2024
AlzeCure Gets Late Breaking Abstract of New Preclinical Data with ACD856 Accepted at AD/PD 2024 Conference
Accesswire 06 Feb 2024
AlzeCure CEO Martin Jönsson to Present at the International Investor Conference BioCapitalEurope
Accesswire 31 Jan 2024